NDMA
The computed 12-month bankruptcy probability of NDMA is 2.6% (moderate). The 2025 annual accounts show equity of €154k and a net result of €75k. Equity is growing by ~84.1% per year across the filed fiscal years. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €154k |
| Net result | €75k |
| Active | 3 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €100k |
| Net profit | €75k |
| Cash flow | €81k |
| Staff costs | - |
| Income taxes | €19k |
| Dividends | - |
| Total assets | €192k |
| Equity | €154k |
| Debt | €38k |
| of which ≤ 1y | €38k |
| of which > 1y | - |
| Working capital | €137k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 4.57 |
| Quick ratio | 4.57 |
| Working capital ratio | 71.2% |
| Solvency | 80.1% |
| Debt / equity | 0.25 |
| Long-term debt ratio | - |
| Interest coverage | 159.41 |
| Gross margin | - |
| Net margin | - |
| ROA | 39.2% |
| ROE | 49.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €192k |
| Fixed assets | 21/28 | €17k |
| Intangible fixed assets | 21 | €13k |
| Tangible fixed assets | 22/27 | €4k |
| Current assets | 29/58 | €175k |
| Amounts receivable within one year | 40/41 | €53k |
| Cash & bank | 54/58 | €122k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €192k |
| Equity | 10/15 | €154k |
| Contributions / capital | 10/11 | €5k |
| Accumulated profits (losses) | 14 | €149k |
| Amounts payable | 17/49 | €38k |
| Amounts payable within one year | 42/48 | €38k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €101k |
| Operating result | 9901 | €95k |
| Financial income | 75 | €2 |
| Financial charges | 65 | €629 |
| Result before taxes | 9903 | €94k |
| Income taxes | 67/77 | €19k |
| Net result for the period | 9904 | €75k |
| Result to be appropriated | 9905 | €75k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 27-12-2022 |
| Status | Active |
| Postal code | 4700 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63302G0013/00Y009 | Wallonia | 811 m² | 1 · 129 m² | 13.7 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
29-12-2022 Incorporation of a new GmbH
Technical details
{
"notary": {
"name": "Philippe MALHERBE",
"firm_city": null,
"firm_name": null,
"office_city": "Eupen",
"is_associated": false
},
"act_meta": {
"language": "de",
"pub_date": "2022-12-29",
"filing_date": "2022-12-27",
"act_kind_objet": "GRUENDUNG",
"is_private_deed": false
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-12-22",
"unanimous": true
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1987-02-11",
"name": "ILIEVA Neli",
"niss": null,
"address": "4802 Verviers (Heusy), rue Jean G\u00F4me 33",
"nationality": "Bulgarije",
"place_of_birth": "Pleven, Bulgarije"
},
"share_class": "Standard",
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 5000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 5000.0,
"is_anonymous_silent_partner": false
}
],
"voorwerp": {
"full_text": "Der Zweck der Gesellschaft ist die Aus\u00FCbung der Medizin und insbesondere die Pneumologie durch den beziehungsweise die Aktion\u00E4re, die sich ausschlie\u00DFlich aus Medizinern zusammensetzen, die entweder in der Liste der \u00C4rztekammer eingetragen sind oder ihre T\u00E4tigkeit im Rahmen einer Gesellschaft von Medizinern aus\u00FCben, die durch die \u00C4rztekammer angenommen wurde. Der Arztberuf wird im Namen und f\u00FCr Konto der Gesellschaft ausge\u00FCbt. Wenn es mehrere Aktion\u00E4re gibt, legen diese ihre gesamten beruflichen T\u00E4tigkeiten innerhalb der Gesellschaft zusammen. Die medizinischen Honorare werden im Namen und f\u00FCr das Konto der Gesellschaft erhoben. Der Gesellschaftszweck darf nur unter Einhaltung der deontologischen Vorschriften ausge\u00FCbt werden, insbesondere derjenigen die sich auf die freie \u00C4rztewahl des Patienten beziehen, auf die diagnostische und therapeutische Unabh\u00E4ngigkeit des Arztes, auf die Einhaltung des Berufsgeheimnisses, sowie auf die W\u00FCrde und die berufliche Unabh\u00E4ngigkeit des Praktikers. Im Rahmen dieses Zweckes, kann die Gesellschaft s\u00E4mtliche Handlungen ziviler, mobilarischer oder immobilarischer Art ausf\u00FChren. Die Gesellschaft untersagt sich jegliche kommerzielle Aus\u00FCbung der Medizin, jegliche Form von direkter oder indirekter Kollusion, Dichotomie oder \u00FCberm\u00E4\u00DFigem Konsum. Die Aktion\u00E4re behalten die unbeschr\u00E4nkte Haftung in der Aus\u00FCbung ihrer beruflichen T\u00E4tigkeit.",
"is_lucrative": false,
"short_summary": "Uitvoering van medische activiteiten, met name pneumologie, door arts die zijn ingeschreven bij de beroepsvereniging of actief zijn binnen een erkende medische samenwerkingsvereniging."
},
"governance": {
"organ_kind": "raad_van_bestuur",
"n_directors_max": null,
"n_directors_min": 1,
"representation_clause": "einziger Verwalter allein",
"co_signature_threshold_eur": null
},
"fiscal_year": {
"end_mm_dd": "12-31",
"start_mm_dd": "01-01",
"first_exercise_end_date": "2023-12-31",
"is_prolonged_first_exercise": false
},
"agm_schedule": {
"time": "18:00",
"month": 6,
"rule_text": "eerste vrijdag juni 18u00"
},
"founding_event": {
"n_shares_total": 100,
"n_share_classes": 1,
"bank_attestation": {
"date": "2022-12-27",
"bank_name": "BNP PARIBAS FORTIS BANK",
"amount_eur": 5000.0,
"iban_masked": "BE90 0019 4329 1532"
},
"amount_paid_in_eur": 5000.0,
"incorporation_date": "2022-12-22",
"amount_subscribed_eur": 5000.0,
"art_5_8_no_payment_due": false,
"pre_incorporation_activity_from_date": null
},
"subject_company": {
"kbo": "0795.447.411",
"email": null,
"region": "waals_gewest",
"website": null,
"name_full": "NDMA",
"legal_form": "GmbH",
"name_abbreviated": null,
"zetel_address_raw": "Vervierser Stra\u00DFe 36A, 4700 Eupen",
"equity_account_type": "available"
},
"initial_directors": [
{
"kind": "natural_person",
"person": {
"name": "ILIEVA Neli",
"address": "4802 Verviers (Heusy), rue Jean G\u00F4me 33"
},
"via_org": null,
"role_sub": "bestuurder",
"mandate_until": {
"kind": "indefinite",
"value": null
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
}
],
"co_filed_documents": [
"expedition",
"statuten",
"bankattest"
],
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameDE | NDMA |